Atlas Trials

A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer

Clinical trial NCT04872608 · WITHDRAWN

Trial details

NCT number
NCT04872608
Sponsor
Memorial Sloan Kettering Cancer Center
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast CancerUnresectable Breast Cancer
Start date
2021-09-09
Primary completion
2023-04-25
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.